Literature DB >> 6378242

Late-stage cutaneous leishmaniasis: immunopathology of tuberculoid lesions in skin and lymph nodes.

D S Ridley, M J Ridley.   

Abstract

Strong development of tuberculoid features in the late stage of cutaneous leishmaniasis presents immunopathological, diagnostic and sometimes therapeutic problems. Only two such cases were identified out of 30 late-stage cases of the disease. They were delineated on histological and immunocytological grounds, and found to present higher levels of Leishmania antigen and lower levels of IgG than the weakly tuberculoid cases. One case showed histological and skin test evidence of delayed-type hypersensitivity; the other case (clinically of the relapsing or recidiva variety) lacked such evidence. Here the residual antigen was segregated at the periphery of the lesion. In three late-stage cases for which lymph node biopsies were available there was a stronger tuberculoid response in lymph node or lymphatic than in the skin lesion. In two cases there was caseation. Germinal follicles were notably active. It is suggested that in cutaneous leishmaniasis a strong tuberculoid response may be associated not so much with immune complex formation (as in the majority of lesions) but with sequestration of antigen at a peripheral site or in the lymphatic apparatus.

Entities:  

Mesh:

Year:  1984        PMID: 6378242      PMCID: PMC2040969     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Three forms of delayed skin-test response evoked by mycobacteria.

Authors:  G A Rook
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

2.  Granuloma formation in lymph nodes.

Authors:  J L Turk
Journal:  Proc R Soc Med       Date:  1971-09

3.  Blast transformation in different stages of cutaneous leishmaniasis.

Authors:  E Witztum; D T Spira; A Zuckerman
Journal:  Isr J Med Sci       Date:  1978-02

4.  Lepromin as an indicator and inducer of protective immunity.

Authors:  M J Lefford
Journal:  Lepr Rev       Date:  1981-12       Impact factor: 0.537

5.  Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase.

Authors:  M J Ridley; D S Ridley
Journal:  Br J Exp Pathol       Date:  1984-06

6.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

7.  A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation.

Authors:  D S Ridley; P D Marsden; C C Cuba; A C Barreto
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

8.  High levels of complement breakdown products in tuberculous pleural effusions.

Authors:  D P Lew; L H Perrin; J D Vassalli; S Suter; P H Lambert; F A Waldvogel
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection.

Authors:  L W Poulter; C R Pandolph
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

10.  Leishmaniasis recidivans treated with sodium stibogluconate.

Authors:  M Schewach-Millet; B K Fisher; D Semah
Journal:  Cutis       Date:  1981-07
  10 in total
  4 in total

1.  Monocyte recruitment, antigen degradation and localization in cutaneous leishmaniasis.

Authors:  M J Ridley; D S Ridley
Journal:  Br J Exp Pathol       Date:  1986-04

2.  Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study.

Authors:  M J Ridley; C W Wells
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

3.  Caseous necrosis in cutaneous leishmaniasis.

Authors:  E Peltier; P Wolkenstein; M Deniau; E S Zafrani; J Wechsler
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

4.  Liver morphology and function in visceral leishmaniasis (Kala-azar).

Authors:  I A el Hag; F A Hashim; I A el Toum; M Homeida; M el Kalifa; A M el Hassan
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.